Axogen, Inc. Income Statement
AXGN / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Axogen, Inc. reported $225M in revenue and $16M in net loss for FY2025. Revenue has grown at a 31.5% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- Negative profit margin: -5.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $225.2M | $187.3M | $159.0M | $138.6M | $127.4M | $112.3M | $106.7M | $83.9M | $60.4M | $41.1M | $27.3M | $16.8M | $7.7M | $7.7M | $4.8M |
| Cost of Revenue | $57.9M | $45.4M | $37.1M | $29.8M | $22.9M | $21.6M | $17.3M | $12.9M | $9.3M | $6.5M | $4.8M | $3.4M | $2.0M | $2.0M | $2.4M |
| Gross Profit | $167.4M | $142.0M | $121.9M | $108.8M | $104.4M | $90.7M | $89.4M | $71.0M | $51.1M | $34.6M | $22.5M | $13.4M | $5.7M | $5.7M | $2.4M |
| SG&A Expense | $44.6M | $39.0M | $38.4M | $40.9M | $32.3M | $26.4M | $31.3M | $23.1M | $14.7M | $10.1M | $8.4M | $6.9M | $5.2M | $5.2M | $4.3M |
| R&D Expense | $32.9M | $27.8M | $27.3M | $25.6M | $24.2M | $17.8M | $17.5M | $11.8M | $6.7M | $4.2M | $3.2M | $3.0M | $1.4M | $1.4M | $697.4K |
| Operating Income | -$7.8M | -$3.3M | -$21.5M | -$29.7M | -$25.4M | -$23.2M | -$31.4M | -$20.5M | -$8.0M | -$8.1M | -$9.3M | -$9.8M | -$7.8M | -$7.8M | -$7.0M |
| Interest Expense | - | - | $2.8M | $624.0K | $1.4M | $1.1M | $40.0K | $1.2M | $2.2M | $5.4M | $4.0M | $6.8M | $1.4M | $1.4M | $1.1M |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$738.2K | -$738.2K | - |
| Net Income | -$15.7M | -$10.0M | -$21.7M | -$28.9M | -$27.0M | -$23.8M | -$29.1M | -$22.4M | -$10.4M | -$14.4M | -$13.4M | -$17.7M | -$9.4M | -$9.4M | -$9.2M |
| EPS (Basic) | -$0.34 | -$0.23 | -$0.51 | -$0.69 | -$0.65 | -$0.60 | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$0.34 | -$0.23 | -$0.51 | -$0.69 | -$0.65 | -$0.60 | -$0.31 | -$0.60 | -$0.51 | -$0.47 | -$0.99 | -$0.99 | -$0.85 | -$0.85 | -$8.35 |
| Shares Outstanding | 47.2M | 44.1M | 43.1M | 42.4M | 41.7M | 40.6M | 38.9M | 38.9M | 33.0M | 33.0M | 19.5M | 19.5M | 11.1M | 11.1M | 1.2M |
| Gross Margin | 74.3% | 75.8% | 76.6% | 78.5% | 82.0% | 80.8% | 83.7% | 84.6% | 84.6% | 84.3% | 82.3% | 79.5% | 74.5% | 74.5% | 50.0% |
| Operating Margin | -3.5% | -1.8% | -13.5% | -21.4% | -20.0% | -20.6% | -29.4% | -24.4% | -13.2% | -19.8% | -33.9% | -58.3% | -101.4% | -101.4% | -143.7% |
| Profit Margin | -7.0% | -5.3% | -13.7% | -20.9% | -21.2% | -21.2% | -27.3% | -26.7% | -17.3% | -35.1% | -48.9% | -105.3% | -122.4% | -122.4% | -190.1% |